Cilostazol D11
| Product Name | Cilostazol D11 |
|---|---|
| Alternate Names | Cilostazol Stable Isotopes, Stable Isotopes of Cilostazol |
| CAT No. | CS-O-02961 |
| CAS No. | 1073608-02-2 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 380.53 g/mol |
| Mol. For. | C₂₀H₁₆D₁₁N₅O₂ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Cilostazol |
| Purity | >98% |
| Smileys | O=C1NC2=CC=C(C=C2CC1)OCCCCC3=NN=NN3C4([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C4([2H])[2H] |
| Canonical Smiles | C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4 |
| InchIKey | RRGUKTPIGVIEKM-SAGHCWGKSA-N |
| Inchl | InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26)/i1D2,2D2,3D2,6D2,7D2,16D |
| IUPAC | 6-[4-[1-(1,2,2,3,3,4,4,5,5,6,6-undecadeuteriocyclohexyl)tetrazol-5-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Cilostazol D11 is a deuterated isotopologue of cilostazol, a medication that is used to treat intermittent claudication. Intermittent claudication is a condition in which there is pain and cramping in the legs during physical activity. Cilostazol D11 works by increasing blood flow to the legs, which reduces the pain and cramping associated with intermittent claudication.
Cilostazol D11 is a phosphodiesterase III inhibitor. It works by inhibiting the enzyme phosphodiesterase III, which leads to an increase in the levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in the body. This increase in cAMP and cGMP leads to vasodilation and inhibition of platelet aggregation, which improves blood flow to the legs.
The chemical formula of cilostazol D11 is C20H14D11N5O2S, and its molecular weight is 409.53 g/mol. It is a white to off-white crystalline powder that is insoluble in water and soluble in ethanol and dimethyl sulfoxide.
Cilostazol D11 is administered orally, usually in a tablet form. The recommended dosage is usually 100 mg twice daily. It is important to follow the dosage instructions provided by the healthcare provider to ensure that the medication is effective and safe. Like any medication, Cilostazol D11 may cause side effects such as headache, diarrhea, dizziness, and palpitations. If any of these side effects persist or worsen, it is important to contact a healthcare provider immediately.
Get an Instant Quote
Related Compounds
Cilostazol D2 | Cilostazol D6 | Cilostazol D4 |